there is a Risk factor which everyone underplays on Natco. No point jumping abt long term nice prdts like cancer drugs for Indian mkt. US market & Copaxone is the big one and there is no ive news. Teva has some success delaying launch & inhlighting need for clinical trials.
11.01 PM Mar 13th
Source:VC Circle - India stunned the pharma industry in 2012 by overriding a valid patent on cancer drug Nexavar from Bayer and issuing a compulsory licence to Natco , allowing the local firm to sell a copy for a fraction of the price. Global drugmakers have had a
11.09 AM Mar 13th
Sun Pharma is the sole supplier of cancer drug in US and number of patients can be multiple in next 4-5 years so its a good news. first indian company to enter in Japanese markets.Sun Pharma gets US FDA nod for zoledronic acid and diabetic drug as well. Its down because of rupee strengthening
4.22 PM Mar 10th
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.